216 related articles for article (PubMed ID: 17040217)
1. Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine.
Petroianu GA; Hasan MY; Nurulain SM; Shafiullah M; Sheen R; Nagelkerke N
Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):312-6. PubMed ID: 17040217
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Nagelkerke N
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):235-40. PubMed ID: 17056080
[TBL] [Abstract][Full Text] [Related]
3. Protective agents in acute high-dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sha Ullah M; Naseer O
J Appl Toxicol; 2005; 25(1):68-73. PubMed ID: 15669039
[TBL] [Abstract][Full Text] [Related]
4. Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon.
Petroianu GA; Nurulain SM; Arafat K; Rajan S; Hasan MY
Arch Toxicol; 2006 Nov; 80(11):777-84. PubMed ID: 16598495
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
[TBL] [Abstract][Full Text] [Related]
6. Tiapride pre-treatment in acute exposure to paraoxon: comparison of effects of administration at different points-in-time in rats.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Shafiullah M; Sheen R
Mol Cell Biochem; 2006 Apr; 285(1-2):79-86. PubMed ID: 16479322
[TBL] [Abstract][Full Text] [Related]
7. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine.
Petroianu GA; Arafat K; Schmitt A; Hasan MY
J Appl Toxicol; 2005; 25(1):60-7. PubMed ID: 15669026
[TBL] [Abstract][Full Text] [Related]
8. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.
Shaikh J; Karanth S; Chakraborty D; Pruett S; Pope CN
Arch Toxicol; 2003 Oct; 77(10):576-83. PubMed ID: 14574445
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon.
Petroianu GA; Nurulain SM; Shafiullah M; Hasan MY; Kuča K; Lorke DE
J Appl Toxicol; 2013 Sep; 33(9):894-900. PubMed ID: 22611016
[TBL] [Abstract][Full Text] [Related]
10. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA
J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864
[TBL] [Abstract][Full Text] [Related]
12. In vivo metoclopramide protection of cholinesterase from paraoxon inhibition: direct comparison with pralidoxime in subchronic low-dose exposure.
Hasan MY; Nurulain SM; Arafat K; Naseer OP; Petroianu GA
J Appl Toxicol; 2004; 24(4):257-60. PubMed ID: 15300712
[TBL] [Abstract][Full Text] [Related]
13. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
[TBL] [Abstract][Full Text] [Related]
14. Pyridostigmine bromide protection against acetylcholinesterase inhibition by pesticides.
Henderson JD; Glucksman G; Leong B; Tigyi A; Ankirskaia A; Siddique I; Lam H; DePeters E; Wilson BW
J Biochem Mol Toxicol; 2012 Jan; 26(1):31-4. PubMed ID: 21972196
[TBL] [Abstract][Full Text] [Related]
15. Reversal of cholinesterase inhibition and clinical signs and the postmortem findings in mice after intraperitoneal administration of anatoxin-a(s), paraoxon or pyridostigmine.
Cook WO; Dahlem AM; Harlin KS; Beasley VR; Hooser SB; Haschek WM; Carmicheal WW
Vet Hum Toxicol; 1991 Feb; 33(1):1-4. PubMed ID: 2017858
[TBL] [Abstract][Full Text] [Related]
16. Protective drugs in acute large-dose exposure to organophosphates: a comparison of metoclopramide and tiapride with pralidoxime in rats.
Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Saleh A; Schmitt A
Anesth Analg; 2005 Feb; 100(2):382-386. PubMed ID: 15673862
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
18. Combined Pre- and Posttreatment of Paraoxon Exposure.
Lorke DE; Nurulain SM; Hasan MY; Kuča K; Petroianu GA
Molecules; 2020 Mar; 25(7):. PubMed ID: 32230733
[TBL] [Abstract][Full Text] [Related]
19. Interactive effects of paraoxon and pyridostigmine on blood-brain barrier integrity and cholinergic toxicity.
Song X; Pope C; Murthy R; Shaikh J; Lal B; Bressler JP
Toxicol Sci; 2004 Apr; 78(2):241-7. PubMed ID: 14976354
[TBL] [Abstract][Full Text] [Related]
20. Effect of intrathecal pralidoxime administration upon survival of rats exposed to the organophosphate paraoxon.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Nagelkerke N; Petroianu GA
Neurotoxicology; 2008 Jul; 29(4):663-70. PubMed ID: 18457881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
